Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy

S. Sivam (Sydney, Australia), K. Wong (Sydney, Australia), A. Piper (Sydney, Australia), D. Wang (Sydney, Australia), B. Yee (Sydney, Australia), R. Grunstein (Sydney, Australia)

Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Disease area: Sleep and breathing disorders

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Sivam (Sydney, Australia), K. Wong (Sydney, Australia), A. Piper (Sydney, Australia), D. Wang (Sydney, Australia), B. Yee (Sydney, Australia), R. Grunstein (Sydney, Australia). Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy. 421

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016


Long-term echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Long-term positive airway pressure therapy in obesity hypoventilation syndrome. Cost study
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019


Efficacy of continous positive airway pressure (CPAP) in the treatment of the obesity hypoventilation syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 726s
Year: 2005

Effectiveness of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnoea-hypopnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 682s
Year: 2006

Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015


Echocardiographic changes with positive airway pressure in obesity hypoventilation syndrome. Pickwick study
Source: International Congress 2017 – CPAP therapy
Year: 2017

Obesity hypoventilation syndrome: efficacy and predictive failure factors for CPAP treatment
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008

Continuous positive airway pressure or NIV in patients with acute and chronic obesity hypoventilation syndrome?
Source: Sleep and Breathing Conference 2021
Year: 2021


Socieconomic factors affecting the acceptance of continuous positive airway pressure in sleep apnoea syndrome patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012

Impact of continuous positive airway pressure therapy on atrial electromechanical delay in obesity-hypoventilation syndrome patients
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015

Long term positive airway pressure effectiveness in obesity hypoventilation syndrome. Pickwick study results
Source: International Congress 2018 – Hot topics in non-invasive ventilation
Year: 2018



Long term effects of compliance with positive airway pressure (PAP) therapy in patients with obesity hypoventilation syndrome (OHS)
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016

Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 320s
Year: 2007

The effect of continuous positive airway pressure on basal metabolism rate in patients with severe obstructive sleep apnea syndrome
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015



Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005

Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013


Compliance of positive airway pressure therapy in patients with sleep related breathing disorder
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Is there a metabolic effect of continuous positive airway pressure in sleep apnoea? Adherence should not be underestimated
Source: Eur Respir J 2009; 34: 1209-1210
Year: 2009


Screening of sleep apnea-induced hypertension and acute effect of continuous positive airway pressure
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009